MG
EVH icon

Michael Gelband’s Evolent Health EVH Stock Holding History

Michael Gelband’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-200,000
Closed -$6.2M – 2280
2021
Q3 		$6.2M Buy
+200,000
New +$4.8M 0.08% 327

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Michael Gelband's EVH Position: Q2 2026 in Review

Michael Gelband increased its Evolent Health (EVH) stake by 968% in Q2 2026, buying an estimated $556K and bringing the position to 159,986 shares worth $867K. The position accounts for 0.01% of the portfolio, ranked #1113.

Michael Gelband first reported a position in EVH in Q2 2019 and has held it in 16 quarters since. The position peaked at $1.23M in Q2 2022. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Michael Gelband held 159,986 shares of Evolent Health worth $867K as of Q2 2026.
  • Michael Gelband bought 145,003 Evolent Health shares in Q2 2026, an estimated $556K.
  • Evolent Health made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #1113 holding.
  • Michael Gelband first reported a position in Evolent Health in Q2 2019 and has held it in 16 quarters since.
  • Michael Gelband's Evolent Health position peaked at $1.23M in Q2 2022.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.